000 01396 a2200373 4500
005 20250517112915.0
264 0 _c20170816
008 201708s 0 0 eng d
022 _a2151-4658
024 7 _a10.1002/acr.23016
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHamann, Philip
245 0 0 _aFactors Associated With Sustained Remission in Rheumatoid Arthritis in Patients Treated With Anti-Tumor Necrosis Factor.
_h[electronic resource]
260 _bArthritis care & research
_c06 2017
300 _a783-793 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Review; Systematic Review
650 0 4 _aAntirheumatic Agents
_xadministration & dosage
650 0 4 _aArthritis, Rheumatoid
_xdiagnosis
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHumans
650 0 4 _aMethotrexate
_xadministration & dosage
650 0 4 _aProspective Studies
650 0 4 _aRemission Induction
_xmethods
650 0 4 _aTreatment Outcome
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
700 1 _aHolland, Richard
700 1 _aHyrich, Kimme
700 1 _aPauling, John D
700 1 _aShaddick, Gavin
700 1 _aNightingale, Alison
700 1 _aMcHugh, Neil
773 0 _tArthritis care & research
_gvol. 69
_gno. 6
_gp. 783-793
856 4 0 _uhttps://doi.org/10.1002/acr.23016
_zAvailable from publisher's website
999 _c26363377
_d26363377